• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLCO1B1*15 单倍型与利福平诱导的肝损伤相关。

SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury.

机构信息

Institute of Digestive Disease, Southwest Hospital, The Third Military Medical University, Chongqing 400038, PR China.

出版信息

Mol Med Rep. 2012 Jul;6(1):75-82. doi: 10.3892/mmr.2012.900. Epub 2012 May 3.

DOI:10.3892/mmr.2012.900
PMID:22562052
Abstract

The organic anion transporting polypeptide 1B1 (OATP1B1, encoded by SLCO1B1) plays an important role in the transport of endogenous and xenobiotic compounds, such as bile acids and rifampin. In this study, the association between OATP1B1 polymorphisms and rifampin hepatotoxicity was investigated using integrated population genetic analysis and functional studies. A total of 273 unrelated patients treated with rifampin were recruited. The allele frequencies were examined in patients with drug (rifampin)-induced liver injury (DILI) (n = 118) and without (non-DILI) (n = 155). Functional analyses were conducted to determine whether the inhibition of bile acids by rifampin was associated with OATP1B1 variants. In the present study, 24 single nucleotide polymorphisms (SNPs) in OATP1B1 were detected in a Chinese population, with two of them causing an amino acid change (rs2306283 and rs4149056). The haplotypes constructed by these two SNPs were OATP1B1 *1a, *1b, *5 and *15, with their respective frequencies being 23.44, 66.30, 0.73 and 9.52% in a total of 273 individuals. The logistic regression analysis indicated that the *15 haplotype was associated with susceptibility to DILI (p = 0.03, OR = 2.04, 95% CI 1.05-3.96). The frequency of the *15 haplotype in DILI patients was significantly higher than that in non-DILI patients (p = 0.03). In the subgroup analysis, the *15 haplotype was associated with susceptibility to cholestatic/mixed injury (p = 0.03, OR = 2.31, 95% CI 1.06-5.02). Functional assessment of the OATP1B1 *15 haplotype revealed that the activity of bile acid uptake was markedly reduced compared to the three other haplotypes. In the inhibition study, the inhibition by rifampin in the *15 haplotype was greater compared to that in the other haplotypes. These results suggest that the OATP1B1 *15 haplotype is an important predisposing factor for rifampin-induced liver injury.

摘要

有机阴离子转运多肽 1B1(OATP1B1,由 SLCO1B1 编码)在运输内源性和外源性化合物(如胆汁酸和利福平)方面发挥着重要作用。在这项研究中,通过整合群体遗传分析和功能研究,研究了 OATP1B1 多态性与利福平肝毒性的关系。共招募了 273 名接受利福平治疗的无相关性患者。在药物(利福平)诱导的肝损伤(DILI)患者(n = 118)和无肝损伤(非-DILI)患者(n = 155)中检测了等位基因频率。进行功能分析以确定利福平对胆汁酸的抑制是否与 OATP1B1 变体有关。在本研究中,在中国人群中检测到 OATP1B1 中的 24 个单核苷酸多态性(SNP),其中两个导致氨基酸变化(rs2306283 和 rs4149056)。由这两个 SNP 构建的单倍型为 OATP1B11a、1b、5 和15,它们在总共 273 个人中的频率分别为 23.44%、66.30%、0.73%和 9.52%。逻辑回归分析表明,15 单倍型与 DILI 易感性相关(p = 0.03,OR = 2.04,95%CI 1.05-3.96)。DILI 患者15 单倍型的频率明显高于非 DILI 患者(p = 0.03)。在亚组分析中,15 单倍型与胆汁淤积/混合损伤的易感性相关(p = 0.03,OR = 2.31,95%CI 1.06-5.02)。对 OATP1B115 单倍型的功能评估表明,与其他三种单倍型相比,胆汁酸摄取的活性明显降低。在抑制研究中,与其他单倍型相比,利福平对15 单倍型的抑制作用更大。这些结果表明,OATP1B115 单倍型是利福平诱导肝损伤的重要易感因素。

相似文献

1
SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury.SLCO1B1*15 单倍型与利福平诱导的肝损伤相关。
Mol Med Rep. 2012 Jul;6(1):75-82. doi: 10.3892/mmr.2012.900. Epub 2012 May 3.
2
Frequency of functional exonic single-nucleotide polymorphisms and haplotype distribution in the SLCO1B1 gene across genetic ancestry groups in the Qatari population.在卡塔尔人群中,SLCO1B1 基因中外显子功能性单核苷酸多态性的频率和单倍型分布与遗传背景有关。
Sci Rep. 2022 Sep 1;12(1):14858. doi: 10.1038/s41598-022-19318-x.
3
Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.SLCO1B1 基因多态性与甲巯咪唑诱导肝损伤易感性的关系。
Basic Clin Pharmacol Toxicol. 2019 Dec;125(6):508-517. doi: 10.1111/bcpt.13284. Epub 2019 Jul 15.
4
Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.芬兰人群中有机阴离子转运多肽1B1(SLCO1B1)基因单核苷酸多态性和单倍型的频率
Eur J Clin Pharmacol. 2006 Jun;62(6):409-15. doi: 10.1007/s00228-006-0123-1. Epub 2006 Apr 21.
5
Fentanyl pharmacokinetics is not dependent on hepatic uptake by organic anion-transporting polypeptide 1B1 in human beings.芬太尼的药代动力学并不依赖于有机阴离子转运多肽 1B1 在人体内的肝摄取。
Basic Clin Pharmacol Toxicol. 2013 Jul;113(1):43-8. doi: 10.1111/bcpt.12066. Epub 2013 Apr 6.
6
The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.APOE 基因的 SNPs rs429358 和 rs7412 与中国南方客家人群的脑梗死相关,但 SLCO1B1 基因的 SNPs rs2306283 和 rs4149056 不相关。
Lipids Health Dis. 2020 Sep 5;19(1):202. doi: 10.1186/s12944-020-01379-4.
7
Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.有机阴离子转运多肽 1B1(OATP1B1)和 OATP1B3:白种加拿大人群的遗传多态性和单倍型分析。
Drug Metab Pharmacokinet. 2010;25(5):508-15. doi: 10.2133/dmpk.dmpk-10-sh-046. Epub 2010 Sep 22.
8
Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15.日本受试者中编码转运蛋白OATP1B1的SLCO1B1的基因变异及主要单倍型频率:SLCO1B1*17比*15更常见。
Drug Metab Pharmacokinet. 2007 Dec;22(6):456-61. doi: 10.2133/dmpk.22.456.
9
Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.中国人群中药物转运蛋白基因(SLCO1B1和SLC10A1)多态性与抗结核药物所致肝毒性的关联
Tuberculosis (Edinb). 2015 Jan;95(1):68-74. doi: 10.1016/j.tube.2014.11.004. Epub 2014 Nov 27.
10
Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.SLCO1B1、CYP2E1和UGT1A1基因多态性与抗结核药物性肝损伤易感性:一项基于中国人群的前瞻性病例对照研究。
Clin Drug Investig. 2017 Dec;37(12):1125-1136. doi: 10.1007/s40261-017-0572-6.

引用本文的文献

1
Genetic polymorphisms and adverse reactions to antituberculosis therapy.基因多态性与抗结核治疗的不良反应
Pharmacogenomics. 2025 Apr-Apr;26(5-6):207-221. doi: 10.1080/14622416.2025.2509479. Epub 2025 Jun 20.
2
Integration of genomics, clinical characteristics and baseline biological profiles to predict the risk of liver injury induced by high-dose methotrexate.整合基因组学、临床特征和基线生物学特征以预测高剂量甲氨蝶呤所致肝损伤风险
Front Pharmacol. 2024 Nov 28;15:1423214. doi: 10.3389/fphar.2024.1423214. eCollection 2024.
3
Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective.
从药物遗传学角度探讨肺结核患者利福平血浆暴露的变异性及抗结核药物性肝损伤的发生情况。
Pharmaceutics. 2024 Mar 12;16(3):388. doi: 10.3390/pharmaceutics16030388.
4
Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?药物遗传学作为非洲人群结核病治疗推荐精准医学的一部分:这会成为现实吗?
Clin Transl Sci. 2023 Jul;16(7):1101-1112. doi: 10.1111/cts.13520. Epub 2023 Jun 8.
5
Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury.SLCO1B1*5对氟氯西林和阿莫西林克拉维酸相关肝损伤的影响。
Front Pharmacol. 2022 Jun 8;13:882962. doi: 10.3389/fphar.2022.882962. eCollection 2022.
6
Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review.药物代谢酶和药物转运体基因变异对利福霉素类药物药代动力学的影响:一项系统评价
Pharmgenomics Pers Med. 2022 Jun 4;15:561-571. doi: 10.2147/PGPM.S363058. eCollection 2022.
7
Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population.泰国人群全基因组测序获得的 51 个药物基因的基因型和表型图谱。
PLoS One. 2022 Feb 17;17(2):e0263621. doi: 10.1371/journal.pone.0263621. eCollection 2022.
8
Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury.机器学习识别单核苷酸多态性相互作用作为慢性药物性肝损伤的风险因素。
Int J Environ Res Public Health. 2021 Oct 10;18(20):10603. doi: 10.3390/ijerph182010603.
9
Research Progress of Pharmacogenomics in Drug-Induced Liver Injury.药物基因组学在药物性肝损伤中的研究进展
Front Pharmacol. 2021 Sep 6;12:735260. doi: 10.3389/fphar.2021.735260. eCollection 2021.
10
Rifampicin Transport by OATP1B1 Variants.OATP1B1 变异体对利福平的转运。
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00955-20.